Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.23 - $319.0 $40,071 - $55.6 Million
-174,225 Reduced 14.88%
996,822 $305,000
Q2 2022

Aug 12, 2022

SELL
$0.19 - $0.45 $6,985 - $16,544
-36,765 Reduced 3.04%
1,171,047 $273,000
Q1 2022

May 13, 2022

SELL
$0.36 - $0.77 $181,425 - $388,048
-503,959 Reduced 29.44%
1,207,812 $471,000
Q4 2021

Feb 14, 2022

SELL
$0.69 - $1.73 $1,419 - $3,558
-2,057 Reduced 0.12%
1,711,771 $1.18 Million
Q3 2021

Nov 12, 2021

BUY
$1.38 - $2.15 $6,524 - $10,165
4,728 Added 0.28%
1,713,828 $2.97 Million
Q2 2021

Aug 13, 2021

BUY
$1.98 - $2.74 $3.38 Million - $4.68 Million
1,709,100 New
1,709,100 $3.73 Million

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $17.7M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.